07-03-2023 | Type 2 diabetes | News
SURMOUNT-2 trial results show bodyweight reductions with tirzepatide that rival those seen with other approved anti-obesity medications in people with type 2 diabetes.
02-14-2023 | Obesity | News
There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.
11-01-2022 | SGLT2 inhibitors | News
People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.
Get the latest results and insights from the researchers.
10-24-2023 | Type 2 diabetes | News
09-25-2023 | Gestational diabetes | News
09-15-2023 | Type 2 diabetes | News
07-28-2023 | Type 2 diabetes | News
Primary findings, 2-year outcomes and translating this landmark trial into practice
07-14-2023 | Type 2 diabetes | News
06-05-2023 | Prediabetes | News
05-04-2023 | Diet | News
04-25-2023 | Diet | News
01-17-2023 | Lifestyle interventions | News